Researchers from Imperial College London and collaborators further investigated C/EBPβ as a target for MASLD and evaluated the efficacy of a C/EBPβ-targeted siRNA approach to reverse metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results